Cambrex Stock Soars (CBM)

NEW YORK ( TheStreet) -- Shares of Cambrex Corporation (NYSE: CBM) have taken a tremendous swing upward. The stock is trading at $5.42 as of 4:01 p.m. ET, 20.2% above Wednesday's closing price of $4.51. Volume is at 188,968, 2.4 times the daily average of 78,300.

Cambrex has a market cap of $134.2 million and is part of the health care sector and drugs industry. Shares are down 12.8% year to date as of the close of trading on Wednesday.

Cambrex Corporation, a life sciences company, provides products and services for the development and commercialization of new and generic therapeutics. The company has a P/E ratio of 12.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Cambrex as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and attractive valuation levels. However, as a counter to these strengths, we find that the company has not been very careful in the management of its balance sheet. You can view the full Cambrex Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.

null

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet